Christer Ruff, Paula Bombach, Constantin Roder, Eliane Weinbrenner, Christoph Artzner, Leonie Zerweck, Frank Paulsen, Till-Karsten Hauser, Ulrike Ernemann, Georg Gohla
{"title":"Multidisciplinary quantitative and qualitative assessment of IDH-mutant gliomas with full diagnostic deep learning image reconstruction.","authors":"Christer Ruff, Paula Bombach, Constantin Roder, Eliane Weinbrenner, Christoph Artzner, Leonie Zerweck, Frank Paulsen, Till-Karsten Hauser, Ulrike Ernemann, Georg Gohla","doi":"10.1016/j.ejro.2024.100617","DOIUrl":null,"url":null,"abstract":"<p><p><b>Rationale and Objectives:</b> Diagnostic accuracy and therapeutic decision-making for IDH-mutant gliomas in tumor board reviews are based on MRI and multidisciplinary interactions.</p><p><strong>Materials and methods: </strong>This study explores the feasibility of deep learning-based reconstruction (DLR) in MRI for IDH-mutant gliomas. The research utilizes a multidisciplinary approach, engaging neuroradiologists, neurosurgeons, neuro-oncologists, and radiotherapists to evaluate qualitative aspects of DLR and conventional reconstructed (CR) sequences. Furthermore, quantitative image quality and tumor volumes according to Response Assessment in Neuro-Oncology (RANO) 2.0 standards were assessed.</p><p><strong>Results: </strong>All DLR sequences consistently outperformed CR sequences (median of 4 for all) in qualitative image quality across all raters (p < 0.001 for all) and revealed higher SNR and CNR values (p < 0.001 for all). Preference for all DLR over CR was overwhelming, with ratings of 84 % from the neuroradiologist, 100 % from the neurosurgeon, 92 % from the neuro-oncologist, and 84 % from the radiation oncologist. The RANO 2.0 compliant measurements showed no significant difference between the CR and DRL sequences (p = 0.142).</p><p><strong>Conclusion: </strong>This study demonstrates the clinical feasibility of DLR in MR imaging of IDH-mutant gliomas, with significant time savings of 29.6 % on average and non-inferior image quality to CR. DLR sequences received strong multidisciplinary preference, underscoring their potential for enhancing neuro-oncological decision-making and suitability for clinical implementation.</p>","PeriodicalId":38076,"journal":{"name":"European Journal of Radiology Open","volume":"13 ","pages":"100617"},"PeriodicalIF":1.8000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11664152/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Radiology Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ejro.2024.100617","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale and Objectives: Diagnostic accuracy and therapeutic decision-making for IDH-mutant gliomas in tumor board reviews are based on MRI and multidisciplinary interactions.
Materials and methods: This study explores the feasibility of deep learning-based reconstruction (DLR) in MRI for IDH-mutant gliomas. The research utilizes a multidisciplinary approach, engaging neuroradiologists, neurosurgeons, neuro-oncologists, and radiotherapists to evaluate qualitative aspects of DLR and conventional reconstructed (CR) sequences. Furthermore, quantitative image quality and tumor volumes according to Response Assessment in Neuro-Oncology (RANO) 2.0 standards were assessed.
Results: All DLR sequences consistently outperformed CR sequences (median of 4 for all) in qualitative image quality across all raters (p < 0.001 for all) and revealed higher SNR and CNR values (p < 0.001 for all). Preference for all DLR over CR was overwhelming, with ratings of 84 % from the neuroradiologist, 100 % from the neurosurgeon, 92 % from the neuro-oncologist, and 84 % from the radiation oncologist. The RANO 2.0 compliant measurements showed no significant difference between the CR and DRL sequences (p = 0.142).
Conclusion: This study demonstrates the clinical feasibility of DLR in MR imaging of IDH-mutant gliomas, with significant time savings of 29.6 % on average and non-inferior image quality to CR. DLR sequences received strong multidisciplinary preference, underscoring their potential for enhancing neuro-oncological decision-making and suitability for clinical implementation.